Preferred Label : posaconazole;
CISMeF synonym : SCH-56592; noxafil;
MeSH synonym : 4-(p-(4-(p-(((3R,5R)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furyl)methoxy)phenyl)-1-piperazinyl)phenyl)-1-((1S,2S)-1-ethyl-2-hydroxypropyl)-delta(sup
2)-1,2,4-triazolin-5-one;
MeSH hyponym : SCH 56592;
Is substance : O;
UNII : 6TK1G07BHZ;
InChIKey : RAGOYPUPXAKGKH-XAKZXMRKSA-N;
Origin ID : C101425;
UMLS CUI : C0936148;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3181649/fr/posaconazole-fresenius-kabi
2020
false
false
false
France
administration, oral
posaconazole
insurance, health, reimbursement
treatment outcome
evaluation of the transparency committee
posaconazole
triazoles
triazoles
---
https://www.has-sante.fr/jcms/p_3151447/fr/posaconazole-zentiva
2020
false
false
false
France
drugs, generic
posaconazole
evaluation of the transparency committee
posaconazole
triazoles
---
https://www.has-sante.fr/jcms/p_3147912/fr/posaconazole-mylan
2020
false
false
false
France
posaconazole
drugs, generic
evaluation of the transparency committee
posaconazole
triazoles
---
https://www.has-sante.fr/jcms/p_3146433/fr/posaconazole-eg
2020
false
false
false
France
drugs, generic
evaluation of the transparency committee
posaconazole
triazoles
---
https://www.ema.europa.eu/en/medicines/human/EPAR/posaconazole-accord
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
posaconazole
drugs, generic
triazoles
---
https://www.has-sante.fr/jcms/p_3069190
2019
France
evaluation of the transparency committee
posaconazole
posaconazole
---
https://www.has-sante.fr/jcms/p_3117999/fr/posaconazole-ahcl
2019
false
false
false
France
administration, oral
posaconazole
antifungal agents
treatment outcome
insurance, health, reimbursement
drugs, generic
aspergillosis
invasive aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
Oropharyngeal Candidiasis
candidiasis, oral
Invasive Fungal Infections
evaluation of the transparency committee
posaconazole
triazoles
---
https://www.has-sante.fr/jcms/p_3117944/fr/posaconazole-accord
2019
false
false
false
France
antifungal agents
administration, oral
posaconazole
treatment outcome
insurance, health, reimbursement
drugs, generic
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
adult
Invasive Fungal Infections
invasive aspergillosis
evaluation of the transparency committee
posaconazole
triazoles
---
https://www.has-sante.fr/jcms/p_3117950/fr/posaconazole-ohre-pharma
2019
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
posaconazole
antifungal agents
drugs, generic
invasive aspergillosis
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
candidiasis, oral
adult
Oropharyngeal Candidiasis
Invasive Fungal Infections
evaluation of the transparency committee
posaconazole
triazoles
---
https://www.ema.europa.eu/en/medicines/human/EPAR/posaconazole-ahcl
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drugs, generic
posaconazole
triazoles
---
Product confusion alert - Posanol (posaconazole) – Oral dosage forms not interchangeable
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-11-fra.php#a2-2
2016
false
false
false
Canada
French
English
administration, oral
medication errors
posaconazole
posaconazole
pharmacovigilance note
canada
antifungal agents
tablets
suspensions
Delayed-Action preparations
biological availability
triazoles
---
http://www.has-sante.fr/portail/jcms/c_2633059/fr/noxafil
2016
false
false
false
France
French
evaluation of the transparency committee
antifungal agents
posaconazole
posaconazole
adult
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
chemoprevention
mycoses
immunocompromised host
treatment outcome
invasive aspergillosis
invasive fungal infection
infusions, intravenous
triazoles
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69380042
2015
false
false
false
France
French
summary of product characteristics
package leaflet
evaluation of the transparency committee
posaconazole
triazoles
---
http://www.has-sante.fr/portail/jcms/c_1778227/fr/noxafil
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
tablets, enteric-coated
antifungal agents
posaconazole
posaconazole
adult
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
chemoprevention
mycoses
immunocompromised host
treatment outcome
invasive aspergillosis
invasive fungal infection
triazoles
---
https://www.jle.com/fr/revues/abc/e-docs/antifongiques_triazoles_interet_et_modalites_du_suivi_therapeutique_pharmacologique_et_perspectives_doptimisation_des_traitements_302259/article.phtml
10.1684/abc.2014.0968
2014
false
false
false
France
French
journal article
mycoses
immune tolerance
antifungal agents
triazoles
fluconazole
itraconazole
14-alpha demethylase inhibitors
posaconazole
Voriconazole
drug monitoring
antifungal agents
triazoles
---
https://www.ema.europa.eu/medicines/human/EPAR/Noxafil
2012
false
United Kingdom
English
French
syndication feed
Contraindications, Procedure
triazoles
antifungal agents
mycoses
triazoles
antifungal agents
triazoles
antifungal agents
triazoles
antifungal agents
antifungal agents
administration, oral
aspergillosis
fusarium
chromoblastomycosis
mycetoma
coccidioidomycosis
candidiasis, oral
immunocompromised host
mycoses
adult
drug interactions
pregnancy
breast feeding
triazoles
triazoles
antifungal agents
drug evaluation, preclinical
triazoles
antifungal agents
drug labeling
drug approval
posaconazole
posaconazole
triazoles
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug
---
https://www.ema.europa.eu/medicines/human/EPAR/Posaconazole-SP
2009
United Kingdom
French
English
syndication feed
Contraindications, Procedure
triazoles
antifungal agents
mycoses
triazoles
antifungal agents
triazoles
antifungal agents
triazoles
antifungal agents
pharmaceutical solutions
administration, oral
adult
immunocompromised host
aspergillosis
fusarium
candidiasis, oral
chromoblastomycosis
coccidioidomycosis
drug labeling
drug approval
treatment outcome
drug evaluation
mycetoma
triazoles
triazoles
antifungal agents
antifungal agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
triazoles
antifungal agents
posaconazole
posaconazole
triazoles
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00110
2008
false
Canada
French
English
aspergillosis
candidiasis
drug approval
canada
aspergillosis
adolescent
adult
candidiasis
drug evaluation, preclinical
drug interactions
treatment outcome
posaconazole
posaconazole
triazoles
triazoles
administration, oral
antifungal agents
antifungal agents
posaconazole
14-alpha demethylase inhibitors
14-alpha demethylase inhibitors
triazoles
package leaflet
drug information
---
http://www.has-sante.fr/portail/jcms/c_574573/fr/noxafil
2007
false
true
false
France
French
English
evaluation of the transparency committee
administration, oral
antifungal agents
posaconazole
posaconazole
adult
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
chemoprevention
mycoses
immunocompromised host
treatment outcome
invasive aspergillosis
invasive fungal infection
pharmaceutical solutions
Oropharyngeal Candidiasis
candidiasis
aspergillosis
triazoles
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Spriafil_January-30-2008_fr.pdf
2007
Canada
French
canada
insurance, health, reimbursement
antifungal agents
candidiasis
aspergillosis
candidiasis
aspergillosis
triazoles
posaconazole
posaconazole
triazoles
drug evaluation
---